Successful Treatment of Transplant Renal Artery Thrombosis With Systemic Infusion of Recombinant-Tissue-Plasminogen Activator After Renal Transplant.

نویسندگان

  • Takashi Yoshida
  • Masaaki Yanishi
  • Takahiro Nakamoto
  • Motohiko Sugi
  • Hidefumi Kinoshita
  • Tadashi Matsuda
چکیده

A 24-year-old man with end-stage renal disease secondary to congenital renal hypoplasia under-went a preemptive renal transplant. Although a vascular complication occurred during surgery, the operation was completed satisfactorily. However, postoperative Doppler ultrasound showed no perfusion of the renal artery, vein, and parenchyma, indicating a transplant renal artery thrombosis. A reoperation was promptly performed, with systemic infusion of recombinant-tissue-plasminogen activator during graft nephrectomy, followed by a reimplant that resulted in a salvage allograft. Immediate thrombolysis using systemically infused recombinant-tissue-plasminogen activator may be an effective treatment option for transplant renal artery thrombosis after renal transplant.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Reply to Hamidian Jahromi and Bastani: Acute early transplant renal artery thrombosis; a complex etiologic diagnosis

Implication for health policy/practice/research/medical education: This article discusses renal artery thrombosis as a complication of distal renal artery stenosis in a kidney transplant recipient. This important complication should be considered in the differential diagnosis of acute kidney injury occurring immediately post-kidney transplantation. Acute early transplant renal artery thrombosis...

متن کامل

گزارش یک مورد آنژیوپلاستی و Stent گذاری موفق در درمان تنگی

    Introduction: Renal transplantation has established itself as the treatment of choice for the majority of patients with End stage renal failure(ESRF). Arterial stenosis is the most common vascular complication after kidney transplantation, occurring in approximately 4%-25% of transplant recipients. Case Report: The patient is a 68 year old man with ESRF due to Poly cystic kidney disease(PCK...

متن کامل

A clinical study investigating the three months prognosis of patients with ischemic stroke treated with recombinant tissue plasminogen activator (rt-PA) and its effective factors

Objective: Currently, treating ischemic stroke by intravenous thrombolytic therapy has acceptable results in patients with stroke. This study aimed to evaluate the three months prognosis of patients treated with recombinant tissue plasminogen activator (rt-PA).Methods: This cross-sectional prospective study was conducted on 30 patients with cerebral ischemic stroke with the National Insti...

متن کامل

Renal transplantation outcome in children with cystinosis

Background and Objective: Cystinosis is a rare inherited disease that leads to renal failure. Fanconi syndrome is the major renal involvement in cystinosis patients. Renal transplantation is the treatment of choice in cystinosis children with end-stage renal disease (ESRD).  The study aimed to assess the outcome of renal transplantation in Iranian children with cystinosis. Methods: This...

متن کامل

Elevated plasminogen activator inhibitor levels in cyclosporin-treated renal allograft recipients.

Atherosclerosis and thrombosis, two major causes of morbidity and mortality in renal transplant recipients, share the same clinical risk factors including decreased fibrinolysis and lipid disturbances. In a cross-sectional study we have determined parameters of fibrinolysis in control subjects (n = 23) and stable renal allograft recipients without cyclosporin (CsA) (n = 10) and with CsA (n = 87...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation

دوره 15 5  شماره 

صفحات  -

تاریخ انتشار 2017